T43.222S Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, sequela

Name of the Condition

• Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, sequela

Summary

This condition represents the long-term effects (sequela) resulting from intentional self-harm involving selective serotonin reuptake inhibitors (SSRIs). SSRIs are antidepressant medications used to treat mood disorders. Intentional self-harm may involve overdose or deliberate exposure to these drugs. The sequela refers to residual or chronic health issues that persist after the initial poisoning event.

Causes

Intentional self-harm by SSRIs typically results from deliberate overdose, such as taking more than the prescribed dose, or ingestion of incorrect doses. It may also occur due to deliberate exposure to these medications. The intent behind the exposure is a key factor in distinguishing this condition from accidental or unintentional poisoning. Sequela develop as a consequence of the initial poisoning event.

Risk Factors

• History of suicidal ideation or previous self-harm attempts.
• Concurrent use of other medications or substances that interact with SSRIs.
• Underlying mental health conditions such as depression or anxiety.
• Access to SSRIs without supervision or proper storage.
• Social or environmental stressors that increase risk of self-harm.

Symptoms

• Persistent neurological symptoms (e.g., dizziness, confusion, or memory issues).
• Chronic gastrointestinal problems (e.g., nausea, abdominal pain).
• Mood disturbances or emotional dysregulation.
• Fatigue or persistent drowsiness.
• Cardiovascular issues (e.g., irregular heart rate or blood pressure changes).
• Respiratory complications (e.g., shortness of breath or reduced lung function).

Diagnosis

Diagnosis involves reviewing the patient’s medical history, including the initial poisoning event and intent. Clinical evaluation assesses residual symptoms and functional impairment. Laboratory tests may be used to rule out other conditions, and imaging or specialized assessments may evaluate organ damage or neurological effects. Documentation of the sequela and their link to the prior intentional self-harm is critical.

Treatment Options

Treatment focuses on managing residual symptoms and supporting recovery. This may include medications to address ongoing effects (e.g., antidepressants for mood changes or therapies for neurological symptoms). Rehabilitation services, such as physical or occupational therapy, may help with functional recovery. Mental health support, including counseling or therapy, is often recommended to address underlying issues.

Prognosis and Follow-Up

Prognosis varies based on the severity of the initial poisoning and the nature of the sequela. Some patients may experience full recovery, while others may have persistent symptoms. Regular follow-up with healthcare providers is essential to monitor progress, adjust treatments, and address any new or worsening symptoms. Long-term care may be needed for chronic conditions.

Complications

• Chronic neurological impairment (e.g., cognitive or motor function issues).
• Persistent mood disorders or emotional instability.
• Gastrointestinal or cardiovascular complications.
• Increased risk of future self-harm or suicidal behavior.
• Reduced quality of life due to ongoing symptoms.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Adherence to prescribed dosing and regular medication reviews.
• Mental health support and therapy to address underlying conditions.
• Avoiding substance use that may interact with SSRIs.
• Building a support network to reduce social or environmental stressors.

When to Seek Professional Help

Seek immediate medical attention if new or worsening symptoms occur, such as severe dizziness, chest pain, difficulty breathing, or signs of depression or suicidal thoughts. Regular follow-up with healthcare providers is important for monitoring sequela and adjusting care plans.

Tips for Medical Coders

This code is used for sequela of intentional self-harm by SSRIs. Document the residual effects and their connection to the prior poisoning event. Ensure the intent (intentional self-harm) and the nature of the sequela are clearly recorded. Follow guidelines for sequencing and reporting to accurately reflect the condition.